Novo Nordisk A/S
SWB:NOVA

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
SWB:NOVA
Watchlist
Price: 40.55 EUR 0.37% Market Closed
Market Cap: 87.2B EUR

Intrinsic Value

The intrinsic value of one NOVA stock under the Base Case scenario is 60.91 EUR. Compared to the current market price of 40.55 EUR, Novo Nordisk A/S is Undervalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NOVA Intrinsic Value
60.91 EUR
Undervaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Novo Nordisk A/S

What is Valuation History?
Ask AI Assistant
What other research platforms think about NOVA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NOVA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Novo Nordisk A/S.

Explain Valuation
Compare NOVA to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NOVO B?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Novo Nordisk A/S

Current Assets 181.9B
Cash & Short-Term Investments 32.6B
Receivables 92.4B
Other Current Assets 56.9B
Non-Current Assets 330.4B
Long-Term Investments 2.7B
PP&E 193.2B
Intangibles 106.6B
Other Non-Current Assets 27.8B
Current Liabilities 234.4B
Accounts Payable 23.9B
Other Current Liabilities 210.5B
Non-Current Liabilities 108B
Long-Term Debt 89.2B
Other Non-Current Liabilities 18.9B
Efficiency

Free Cash Flow Analysis
Novo Nordisk A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Novo Nordisk A/S

Revenue
315.6B DKK
Cost of Revenue
-56.7B DKK
Gross Profit
258.9B DKK
Operating Expenses
-126.3B DKK
Operating Income
132.7B DKK
Other Expenses
-28.9B DKK
Net Income
103.8B DKK
Fundamental Scores

NOVA Profitability Score
Profitability Due Diligence

Novo Nordisk A/S's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional 3Y Average ROIC
Exceptional ROE
Exceptional Operating Margin
74/100
Profitability
Score

Novo Nordisk A/S's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

NOVA Solvency Score
Solvency Due Diligence

Novo Nordisk A/S's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
70/100
Solvency
Score

Novo Nordisk A/S's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NOVA Price Targets Summary
Novo Nordisk A/S

Wall Street analysts forecast NOVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NOVA is 53.79 EUR with a low forecast of 35.67 EUR and a high forecast of 98.89 EUR.

Lowest
Price Target
35.67 EUR
12% Downside
Average
Price Target
53.79 EUR
33% Upside
Highest
Price Target
98.89 EUR
144% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NOVO B is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

NOVA News

Other Videos
What is the Intrinsic Value of one NOVA stock?

The intrinsic value of one NOVA stock under the Base Case scenario is 60.91 EUR.

Is NOVA stock undervalued or overvalued?

Compared to the current market price of 40.55 EUR, Novo Nordisk A/S is Undervalued by 33%.

Back to Top